News

Oxford Endovascular Ltd raises $10m to develop its origami engineered medical device to prevent brain haemorrhage

Posted on

Funding will support the company to achieve first-in-human data Oxford, UK, 8th April 2021 – Oxford Endovascular, a pioneering British MedTech company and spinout from Oxford University, is developing a treatment for brain aneurysms, that will overcome challenges with existing medical devices. It has just raised $10m in a series A funding round. The funding […]

News

Oxford Endovascular wins Innovate UK Smart Grant

Posted on

Press Release: Oxford, UK, 14th November 2020.   Oxford Endovascular Ltd, the developer of advanced neurovascular technologies to save lives of patients suffering from brain aneurysms has been awarded non-dilutive grant funding of £350,000 match funded by the company with £150,000 via the prestigious Smart Grant Program run by Innovate UK, the UK’s innovation agency* […]

News

Oxford Endovascular awarded non-dilutive grant funding of up to 2.96 Million Euros to support R&D activities and clinicals

Posted on

  ‘Next Generation Flow Diverter for the Treatment of Intracranial Aneurysms Delivering Improved Patient Outcomes and Healthcare Cost Savings — OXIFLOW’   This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 859001   Mike Karim, CEO, commented:   ‘We are delighted to have won this prestigious grant […]

News

Oxford Endovascular presents its next investment opportunity as it seeks $8M at the Med Tech Showcase, San Francisco, 9 Jan, 2019

Posted on

Oxford Endovascular, a spin-out from Oxford University, has used ‘origami engineering for the brain’ to develop a unique, patented, next-generation flow-diverter (OxiFlow) for the minimally invasive treatment of intracranial aneurysms – a market around $1 Billion, 8% CAGR. The device has been designed by world leading Professors of Medicine & Engineering. OxiFlow, is inserted via […]